Position in ILMN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$738,486
+$501,061 QoQ
Shares Held
4,200
+68.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#501
of 932 holders
Holding Since
Jun 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ILMN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Catalyst Funds Management Pty Ltd holds $17,014,989 across 10 Diagnostics & Research names. ILMN ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
73,300 | $10,997,199 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
4,360 | $2,185,929 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,821 | $958,647 | |
| 4 | ILMN |
Illumina, Inc.
This page
|
4,200 | $738,486 | |
| 5 | VCYT |
Veracyte, Inc.
|
9,650 | $566,744 | |
| 6 | WAT |
Waters Corp /De/
|
1,360 | $510,054 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
2,251 | $434,938 | |
| 8 | CRL |
Charles River Laboratories International, Inc.
|
950 | $215,450 |
All Filings in ILMN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $738,486 | 4,200 | Shares | Sole | 2026-08-10 | |
| 2025-09-30 | $237,425 | 2,500 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $2,204,895 | 16,500 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $104,328 | 800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,438 | 100 | Shares | Sole | 2024-12-18 | |
| No filing history on record for this holder in this stock. | ||||||